9552 — M&A Research Institute Holdings Income Statement
0.000.00%
Last trade - 00:00- ¥61bn
- ¥56bn
- ¥17bn
- 86
- 28
- 12
- 35
Annual income statement for M&A Research Institute Holdings, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 376 | 1,328 | 3,912 | 8,643 | 16,550 |
| Cost of Revenue | |||||
| Gross Profit | 262 | 1,039 | 3,123 | 6,617 | 12,018 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 373 | 765 | 1,808 | 4,156 | 8,143 |
| Operating Profit | 3.29 | 563 | 2,104 | 4,486 | 8,407 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 3.91 | 558 | 2,083 | 4,485 | 8,404 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 4.25 | 368 | 1,327 | 2,647 | 5,789 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 4.25 | 368 | 1,327 | 2,647 | 5,789 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 4.25 | 368 | 1,327 | 2,647 | 5,789 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.077 | 6.62 | 21.5 | 42.1 | 90.5 |
| Dividends per Share |